Anthropic’s IPO pitch pairs breakneck growth with an $80.7 billion reality check
Anthropic’s IPO pitch pairs breakneck growth with an $80.7 billion reality check
Anthropic has taken its first formal step toward Wall Street, filing an S-1 registration statement for a proposed Nasdaq listing under the ticker ANT. The number of shares and price range remain undecided, and the securities cannot be sold until the registration becomes effective.
The public filing turns a closely watched AI startup into a far more legible — and more complicated — investment proposition. Anthropic says AI could speed scientific discovery, lift economic growth and bring major disease cures within reach, but insists those gains must be pursued while preventing the dangers of a technology moving at unprecedented speed.
Its numbers explain the market’s fascination. Revenue reached $16.3 billion in the first six months of 2026, roughly 13.5 times the comparable period a year earlier. Yet the same period produced an $80.7 billion net loss — a headline figure largely driven by a $72.4 billion accounting charge tied to the rising value of convertible notes. Operating losses, by contrast, narrowed to $693 million, while adjusted operations generated a $1.6 billion profit and $3.9 billion in operating cash flow.
Then comes the bill for growth. Anthropic disclosed commitments running into the hundreds of billions of dollars for cloud capacity, chips and infrastructure, including major arrangements with Broadcom, Google, Microsoft, Amazon and SpaceX. Its top five customers supplied about a quarter of revenue in the first nine months of the year — rapid commercial traction, but also a dependency investors will have to price in.
The prospectus also makes clear that this will not be a conventional public-company handover. Seven co-founders will retain 50.1% of voting power through a single Class F share held by their Founder LLC, a structure Anthropic says protects long-term strategy from pressure for short-term results.
That tension runs through the filing: a safety-focused lab seeking public capital to scale at historic speed, while warning investors that harmful or even “catastrophic” AI incidents could overwhelm available insurance and damage its reputation.
Write a comment